USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer
checkpoint、mutation、inhibitors、specific、clinical、cancer、driver、with、associated、efficacy
24
TP302.8;O621.3+3;R6
2023-02-16(万方平台首次上网日期,不代表论文的发表时间)
共15页
143-156,中插1-中插9